lidocaine has been researched along with flurbiprofen in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (6.45) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (32.26) | 29.6817 |
2010's | 16 (51.61) | 24.3611 |
2020's | 3 (9.68) | 2.80 |
Authors | Studies |
---|---|
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Caron, G; Ermondi, G | 1 |
Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
Carrupt, PA; Martel, S; Ottaviani, G | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Dionne, RA | 1 |
Verstraete, M | 1 |
Nishiyama, T | 1 |
Fujii, Y; Itakura, M | 2 |
Taylor, LS; Van Eerdenbrugh, B | 1 |
He, G; Liu, Z; Lu, H; Ma, H; Wang, J | 1 |
Miller, AF; Saiani, A; Tang, C | 1 |
Abbas, N; Ahmad, Z; Akhlaq, M; Arshad, MS; Bukhari, NI; Hanif, S; Hussain, A; Hussain, K; Syed, MA | 1 |
Bai, WJ; Lan, K; Li, Q; Xu, T; Yang, WB; Zhang, XW | 1 |
Glatz, Z; Michalcová, L; Nevídalová, H | 1 |
Fu, J; Lu, G; Sun, W; Ye, X; Yu, J | 1 |
Kozak, J; Lamprecht, A; Rabiskova, M | 1 |
2 review(s) available for lidocaine and flurbiprofen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprofen; Humans; Hydroxychloroquine; Lidocaine; Platelet Aggregation; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |
6 trial(s) available for lidocaine and flurbiprofen
Article | Year |
---|---|
Suppression of dental pain by the preoperative administration of flurbiprofen.
Topics: Acetaminophen; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Etidocaine; Flurbiprofen; Humans; Lidocaine; Oxycodone; Pain, Postoperative; Premedication; Propionates; Random Allocation; Tooth Extraction | 1986 |
How to decrease pain at rapid injection of propofol: effectiveness of flurbiprofen.
Topics: Adult; Aged; Analgesics; Anesthetics, Intravenous; Anesthetics, Local; Female; Flurbiprofen; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Pain; Preanesthetic Medication; Propofol | 2005 |
Comparison of lidocaine, metoclopramide, and flurbiprofen axetil for reducing pain on injection of propofol in Japanese adult surgical patients: a prospective, randomized, double-blind, parallel-group, placebo-controlled study.
Topics: Adult; Aged; Analgesics; Anesthetics, Intravenous; Anesthetics, Local; Double-Blind Method; Female; Flurbiprofen; Humans; Injections, Intravenous; Japan; Lidocaine; Male; Metoclopramide; Middle Aged; Pain; Pain Measurement; Propofol; Prospective Studies; Surgical Procedures, Operative; Treatment Outcome; Young Adult | 2008 |
Efficacy of the lidocaine/flurbiprofen axetil combination for reducing pain during the injection of propofol.
Topics: Adult; Aged; Anesthesia, General; Anesthesia, Intravenous; Anesthetics, Intravenous; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Combinations; Elective Surgical Procedures; Female; Flurbiprofen; Humans; Injections; Lidocaine; Male; Middle Aged; Pain; Propofol; Young Adult | 2011 |
Non-steroidal anti-inflammatory drugs reduce the stress response during sevoflurane anesthesia.
Topics: Adult; Anesthesia, Inhalation; Anesthetics, Inhalation; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cyclooxygenase 2 Inhibitors; Female; Flurbiprofen; Heart Rate; Humans; Infusions, Intravenous; Intraoperative Complications; Isoxazoles; Lidocaine; Male; Methyl Ethers; Middle Aged; Prospective Studies; Pulmonary Alveoli; Sevoflurane; Skin; Sodium Channel Blockers; Young Adult | 2012 |
[Application of flurbiprofen axetil in pain management associated during transrectal ultrasound-guided prostate biopsy].
Topics: Anesthetics, Local; Biopsy; Flurbiprofen; Humans; Lidocaine; Male; Nerve Block; Pain Management; Prostatic Neoplasms | 2017 |
23 other study(ies) available for lidocaine and flurbiprofen
Article | Year |
---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation.
Topics: Acrylates; Benzamides; Chlorpropamide; Chlorzoxazone; Chromatography, High Pressure Liquid; Crystallization; Flurbiprofen; Hypromellose Derivatives; Imidazoles; Lidocaine; Methylcellulose; Phenacetin; Polymers; Polyvinyls; Povidone; Pyrrolidines; Solvents | 2010 |
Peptide hydrogels as mucoadhesives for local drug delivery.
Topics: Adhesiveness; Chemistry, Pharmaceutical; Drug Carriers; Flurbiprofen; Hydrogels; Kinetics; Lidocaine; Membranes, Artificial; Mucous Membrane; Oligopeptides; Solubility; Technology, Pharmaceutical; Viscosity | 2014 |
Development of an ANN optimized mucoadhesive buccal tablet containing flurbiprofen and lidocaine for dental pain.
Topics: Adhesiveness; Administration, Buccal; Alginates; Anesthetics, Local; Cyclooxygenase Inhibitors; Drug Compounding; Flurbiprofen; Glucuronic Acid; Hexuronic Acids; Humans; Hypromellose Derivatives; Kinetics; Lidocaine; Models, Chemical; Mouth Mucosa; Neural Networks, Computer; Solubility; Tablets; Technology, Pharmaceutical; Toothache | 2016 |
Applicability of capillary electrophoresis-frontal analysis for displacement studies: Effect of several drugs on l-tryptophan and lidocaine binding to human serum albumin.
Topics: Binding Sites; Chlorpropamide; Diclofenac; Electrophoresis, Capillary; Flurbiprofen; Humans; Ibuprofen; Lidocaine; Phenylbutazone; Serum Albumin, Human; Tolbutamide; Tryptophan | 2020 |
Clinical therapeutic effects of lidocaine combination with flurbiprofen axetil for reducing propofol-induced pain in adults: A protocol for systematic review and meta-analysis.
Topics: Adult; Anesthetics, Intravenous; Anesthetics, Local; Drug Therapy, Combination; Flurbiprofen; Humans; Lidocaine; Meta-Analysis as Topic; Pain, Procedural; Propofol; Research Design; Systematic Reviews as Topic; Treatment Outcome | 2020 |
Muscle Tissue as a Surrogate for In Vitro Drug Release Testing of Parenteral Depot Microspheres.
Topics: Animals; Cellulose; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Excipients; Flurbiprofen; In Vitro Techniques; Infusions, Parenteral; Lidocaine; Microspheres; Muscles; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; Swine | 2021 |